https://hh-publisher.com/ojs321/index.php/pmmb <p> </p> <table style="height: 522px; width: 706px;"> <tbody> <tr style="height: 66px;"> <td style="width: 248px; height: 127px;" rowspan="2"> <img src="http://journals.hh-publisher.com/public/journals/1/journalThumbnail_en_US.jpg" alt="" width="230" height="313" /></td> <td style="width: 357px; height: 66px;"> <p style="text-align: justify;"><em><strong>Progress in Microbes and Molecular Biology</strong></em> publishes rigorously peer-reviewed research across a complete range of microbiology and molecular biology. This journal is devoted to advancing and disseminating knowledge in the human microbiome, environmental microbiology, medical microbiology, applied microbiology, virology, molecular biology, biochemistry, genetics, and biotechnology. Covering the fundamentals, application, and advances of microbiology, molecular biology, genetics, biotechnology, and biological sciences.</p> <p><strong><em> </em></strong></p> <p><em><strong>Progress in Microbes and Molecular Biology</strong></em> accepts original research articles, review articles, focused review articles, mini reviews, systematic reviews, reflective reviews, methods, case reports, mini reports, genome reports, and editorials on microbiology, molecular biology, genetics, biotechnology, and biological sciences.</p> <p>eISSN: 2637-1049</p> </td> </tr> </tbody> </table> <p style="text-align: Left;"><em><strong><a href="http://journals.hh-publisher.com/index.php/pmmb/about/submissions#onlineSubmissions">ONLINE SUBMISSION</a> </strong></em></p> <p style="text-align: Left;"><strong>CiteScore: 9.2</strong></p> <p style="text-align: Left;"><strong>Journal Rank: <a href="https://www.scopus.com/sourceid/21101094440">Q1</a> (Top 7%) </strong>_{[<em>Scopus: Biochemistry, Genetics, and Molecular Biology (miscellaneous)</em>]}</p> <p style="text-align: Left;"><strong>Article Processing Charge</strong>: USD 2850 _{(Original Research &amp; Method Article)} or USD 1950 _{(Review and other article formats)}</p> <p style="text-align: Left;">_{*Author requests for APC waivers and discounts will be considered case-by-case.}</p> HH PUBLISHER en-US Progress In Microbes & Molecular Biology 2637-1049 <p>Author(s) shall retain the copyright of their work and grant the Journal/Publisher right for the first publication with the work simultaneously licensed under:</p><p>Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows for the copying, distribution and transmission of the work, provided the correct attribution of the original creator is stated. Adaptation and remixing are also permitted.</p><p> <img src="https://licensebuttons.net/l/by-nc/3.0/88x31.png" alt="" /></p><p>This broad license intends to facilitate free access to, as well as the unrestricted reuse of, original works of all types for non-commercial purposes.</p><p>The author(s) permits <strong>HH Publisher</strong> to publish this article that has not been submitted elsewhere.</p> https://hh-publisher.com/ojs321/index.php/pmmb/article/view/1314 <p>Microbial siderophores are low-molecular-weight compounds with a strong affinity for ferric (FSe³⁺) ions. They play a pivotal role in plant-microbial interactions by enhancing iron bioavailability to plants, primarily through the chelation and mobilization of iron under iron-limited conditions. Their versatile and multifunctional nature has positioned them as promising agents for sustainable and eco-friendly agriculture. However, the practical application of siderophore-based systems is constrained by challenges related to stability, bioavailability, environmental degradation, and large-scale production. This review examines recent advancements in siderophore-mediated agricultural practices and applications, with a focus on formulation strategies and delivery systems, including seed coatings, foliar sprays, and nanoparticle-based encapsulation approaches. The review further highlights key technological innovations integrating nanotechnology, microbiology, and artificial intelligence (AI) for precision agriculture. Particular emphasis is placed on controlled-release systems, production scalability, and field-level applicability. Existing knowledge gaps, particularly in large-scale production and commercialization, are discussed alongside future prospects involving synthetic biology and engineered microbial systems. Siderophore-based technologies represent a transformative approach toward enhancing soil health, crop productivity, and sustainable bioeconomy development.</p> Ayush Madan Rishabh Garg Manjoo Rani Saty Dev Sony Singh Nand Kumar Singh Mukul Machhindra Barwant Ramandeep Saini Himanshu Sharma Yuan Seng Wu Copyright (c) 2026 Ayush Madan, Rishabh Garg, Manjoo Rani, Saty Dev, Sony Singh, Nand Kumar Singh, Mukul MMachhindra Barwant, Ramandeep Saini, Himanshu Sharma, Yuan Seng Wu https://creativecommons.org/licenses/by-nc/4.0 2026-05-04 2026-05-04 9 1 10.36877/pmmb.a0000478 https://hh-publisher.com/ojs321/index.php/pmmb/article/view/1326 <p>The gut microbiome plays a significant role in human health and disease pathogenesis. In preterm infants, gut dysbiosis often results in early dominance of opportunistic pathogens, particularly members of the <em>Enterobacteriaceae </em>family. <em>Enterobacteriaceae </em>can serve as potential reservoirs of opportunistic pathogens, antibiotic-resistance determinants and may contribute to major neonatal morbidities, including necrotizing enterocolitis (NEC) and late-onset sepsis (LOS). This study aims to isolate and identify <em>Enterobacteriaceae</em>, as well as to explore the diversity of isolated <em>Klebsiella pneumoniae</em> from meconium/early stool samples of preterm infants collected from a neonatal intensive care unit (NICU) in Johor Bahru, Malaysia. A combination of culture-based isolation technique, phenotypic and genotypic identification methods was used to identify the culturable <em>Enterobacteriaceae </em>in the gut of preterm infants. Three main bacterial families were successfully isolated and identified from the stool samples of preterm infants, which include <em>Enterobacteriaceae</em>, 46% (76/166 isolates), <em>Staphylococcaceae</em>, 22% (37/166), <em>Enterococcaceae</em>, 22% (37/166) and others, 10% (16/166). It was clear that <em>Enterobacteriaceae</em> was one of the predominant bacterial groups during the early gut colonization in preterm infants, making up to 46% of all isolates. Within the <em>Enterobacteriaceae</em> family, <em>K. pneumoniae</em>, 74% (56/76 isolates) dominates, followed by <em>Escherichia coli</em>, 15% (11/76), <em>Klebsiella aerogenes</em>, 9% (7/76), <em>Citrobacter europaeus</em>, 1% (1/76), and <em>Citrobacter freundii</em>, 1% (1/76). The high number of <em>Enterobacteriaceae </em>isolates, particularly <em>K. pneumoniae</em>, followed by <em>E. coli</em> are concerning as these bacterial species are often associated with hospital-acquired infections in the NICU. Our findings provide insight into the early gut colonization patterns of culturable gut bacteria in preterm infants. It highlights the importance of continuous microbiological monitoring and infection control measures within the NICU to mitigate potential <em>Enterobacteriaceae</em>-associated infections.</p> Angel Yun-Kuan Thye Yatinesh Kumari Kok-Gan Chan Jimmy Kok-Foo Lee Loh Teng-Hern Tan Vengadesh Letchumanan Learn-Han Lee Jodi Woan-Fei Law Copyright (c) 2026 Angel Yun-Kuan Thye, Yatinesh Kumari, Kok-Gan Chan, Jimmy Kok-Foo Lee, Loh Teng-Hern Tan, Vengadesh Letchumanan, Learn-Han Lee, Jodi Woan-Fei Law https://creativecommons.org/licenses/by-nc/4.0 2026-05-15 2026-05-15 9 1 10.36877/pmmb.a0000479